AbbVie Inc. · 2020 Q4
ReportedFeb 3, 2021
Period endedDec 31, 2020
Rule of 40+92
Reported this quarter
Revenue
$13.86B
QoQ +7.4%
YoY —
EPS
-$0.13
QoQ —
YoY —
Free Cash Flow
$4.58B
QoQ -18.5%
YoY —
Gross Margin
66.2%
QoQ +5.3 pp
YoY —
FCF Margin
33.0%
QoQ -10.5 pp
YoY —
P/E Ratio
30.6
QoQ +105.1%
YoY —
Each tile opens the full quarterly series. Download the numbers as CSV or JSON.
Sources & downloads
Company
Published by the company on the day of the release.
HTML
Earnings press release
Investor relations announcement
SEC filings
Filed with the SEC under CIK 1551152.
HTML
8-K results announcement
Filed Feb 3, 2021
HTM
Press release (EX-99.1)
Exhibit 99.1 to the 8-K
575 KB
HTML
Filing index
Every document in the 8-K submission
TXT
Complete submission
Raw archival text of the whole filing
HTML
10-K annual report
Period ended Dec 31, 2020, filed Feb 19, 2021
ZIP
XBRL data bundle
Structured financial statements from the 10-K
JSON
Company facts (XBRL)
Every figure ABBV has reported to the SEC
R40 data
The numbers shown on this page, as we hold them.
CSV
This quarter (CSV)
Reported metrics for 2020 Q4, spreadsheet-ready
JSON
This quarter (JSON)
Metrics, dates and matched filings